Bgm (BGM) Accounts Payables (2019 - 2025)
Bgm's (BGM) quarterly Accounts Payables came in at $6.6 million in Q3 2025, up 58.9% year-on-year from $4.1 million in Q3 2024, and down 22.2% on a QoQ basis from $8.4 million in Q1 2025.
Bgm (BGM) Accounts Payables (2019 - 2025) Analysis & Trends
Bgm (BGM) has 7 years of Accounts Payables data on file, last reported at $6.6 million in Q3 2025.
- On a quarterly basis, Accounts Payables rose 58.9% year-over-year to $6.6 million in Q3 2025; TTM through Sep 2025 was $6.6 million, a 58.9% increase from a year earlier, with the FY2025 full-year figure at $6.6 million, up 58.9% from the prior year.
- Accounts Payables for Q3 2025 stood at $6.6 million, down from $8.4 million in the prior quarter.
- Over the last five years, Accounts Payables for BGM reached as high as $5021.4 billion in Q1 2022 and fell as low as $2.7 million in Q1 2024.
- Historically, Accounts Payables has averaged $1046.0 billion across 5 years, with a median of $6.6 million in 2025.
- Across the five-year window, Accounts Payables plunged 100.0% in 2024 and jumped 215.35% in 2025, its largest moves.
- Year by year, Accounts Payables stood at $6.6 million in 2021, then decreased by 20.38% to $5.3 million in 2022, then plunged by 32.08% to $3.6 million in 2023, then increased by 14.83% to $4.1 million in 2024, then jumped by 58.9% to $6.6 million in 2025.
- Per Business Quant data, the three most recent Accounts Payables figures were $6.6 million in Q3 2025, $8.4 million in Q1 2025, and $4.1 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 498.30 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | 731,000.00 |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Bgm | 33.55 Mn | 23.73 Mn | - | 6.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 6.56 Mn |
| Mar 31, 2025 | 8.43 Mn |
| Sep 30, 2024 | 4.13 Mn |
| Mar 31, 2024 | 2.67 Mn |
| Sep 30, 2023 | 3.59 Mn |
| Mar 31, 2023 | 4,392.30 Bn |
| Sep 30, 2022 | 5.29 Mn |
| Mar 31, 2022 | 5,021.37 Bn |
| Sep 30, 2021 | 6.64 Mn |
| Sep 30, 2020 | 4.38 Mn |
| Sep 30, 2019 | 3.57 Mn |